The Rise of the Omicron SARS-CoV-2 Variant of Concern: Uncertainties Remain, But Readiness Is All .
OrthoEvidence Journal (OE Journal) - OE Original
OE Journal. 2021;9(23):2The emergence of the Omicron variant quickly shifted global attention as scientists noted more than 50 mutations—many on the spike protein—raising concerns about faster spread and possible immune escape. Early reports showed rapid international detection, prompting WHO and EU/EEA officials to label the overall risk as high to very high, even as major uncertainties remained. Researchers are still working to understand how transmissible Omicron truly is and how well current vaccines protect against infection, severe illness, and reinfection. While evidence continues to evolve, public health agencies emphasize readiness: strengthening surveillance, accelerating vaccination, maintaining proven protective measures, and ensuring clear communication so systems can respond quickly if Omicron behaves more aggressively than expected.
Unlock the Full original article
You have access to 4 more FREE articles this month.
Click below to unlock and view this original article
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!